Literature DB >> 22135114

Long-term assessment of contrast effects of gadofluorine M and gadofluorine P in magnetic resonance imaging of mice.

Fugeng Sheng1, Yusuke Inoue, Shigeru Kiryu, Makoto Watanabe, Kuni Ohtomo.   

Abstract

PURPOSE: To investigate the long-term time course of the contrast effects after the intravenous injection of gadofluorine M or gadofluorine P in mice.
MATERIALS AND METHODS: Magnetic resonance images were acquired longitudinally after intravenous injection of 0.1 μmol Gd/g gadofluorine M into BALB/c mice. The contrast effects were also assessed in C57BL/6J mice injected with gadofluorine M, BALB/c mice injected with gadofluorine P, and BALB/c mice injected with a double dose of gadopentetate dimeglumine.
RESULTS: The injection of gadofluorine M into BALB/c mice caused prolonged contrast effects in the blood and other organs. The liver enhancement was especially long-lasting and still evident 6 days after injection. Strain-related differences in contrast kinetics of gadofluorine M were not observed between BALB/c mice and C57BL/6J mice. In comparison with gadofluorine M, clearances from the blood, liver, and kidney were more rapid and contrast enhancement in the spleen was generally lower for gadofluorine P. The enhancement in the gallbladder cavity, indicating biliary excretion, was evident only after gadofluorine P injection. Blood enhancement at 10 min was much weaker for gadopentetate dimeglumine.
CONCLUSION: Both gadofluorine M and gadofluorine P appear to be applicable to blood pool imaging and liver imaging in mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22135114     DOI: 10.1007/s11604-011-0009-8

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  16 in total

Review 1.  Nuclear magnetic resonance spectroscopy and imaging in animal research.

Authors:  J C Chatham; S J Blackband
Journal:  ILAR J       Date:  2001

2.  Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.

Authors:  Martin Bendszus; Gesa Ladewig; Leonie Jestaedt; Bernd Misselwitz; Laszlo Solymosi; Klaus Toyka; Guido Stoll
Journal:  Brain       Date:  2008-07-24       Impact factor: 13.501

Review 3.  Classification and basic properties of contrast agents for magnetic resonance imaging.

Authors:  Carlos F G C Geraldes; Sophie Laurent
Journal:  Contrast Media Mol Imaging       Date:  2009 Jan-Feb       Impact factor: 3.161

4.  MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agent.

Authors:  Hans-Jürgen Raatschen; Rebecca Swain; David M Shames; Yanjun Fu; Zachary Boyd; Matthew L Zierhut; Michael F Wendland; Bernd Misselwitz; Hanns-Joachim Weinmann; Karl-Jürgen Wolf; Robert C Brasch
Journal:  Contrast Media Mol Imaging       Date:  2006 May-Jun       Impact factor: 3.161

5.  Assessment of nerve degeneration by gadofluorine M-enhanced magnetic resonance imaging.

Authors:  Martin Bendszus; Carsten Wessig; Ansgar Schütz; Tanja Horn; Christoph Kleinschnitz; Claudia Sommer; Bernd Misselwitz; Guido Stoll
Journal:  Ann Neurol       Date:  2005-03       Impact factor: 10.422

6.  Imaging living mice using a 1-T compact MRI system.

Authors:  Yusuke Inoue; Yukihiro Nomura; Tomoyuki Haishi; Kohki Yoshikawa; Takahiro Seki; Kyoko Tsukiyama-Kohara; Chieko Kai; Toshiyuki Okubo; Kuni Ohtomo
Journal:  J Magn Reson Imaging       Date:  2006-10       Impact factor: 4.813

7.  Gadobenate dimeglumine as a contrast agent for MRI of the mouse liver.

Authors:  Yusuke Inoue; Kohki Yoshikawa; Yukihiro Nomura; Kiyoko Izawa; Morio Shimada; Arinobu Tojo; Kuni Ohtomo
Journal:  NMR Biomed       Date:  2007-12       Impact factor: 4.044

8.  Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging.

Authors:  Jörg Barkhausen; Wolfgang Ebert; Claudia Heyer; Jörg F Debatin; Hanns-Joachim Weinmann
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

9.  Early MR lymphography with gadofluorine M in rabbits.

Authors:  Bernd Misselwitz; Johannes Platzek; Hanns-Joachim Weinmann
Journal:  Radiology       Date:  2004-06       Impact factor: 11.105

10.  Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model.

Authors:  Saskia Schmidt; Antje Vieweger; Michael Obst; Susanne Mueller; Volkmar Gross; Matthias Gutberlet; Jens Steinbrink; Semjon Taubert; Bernd Misselwitz; Lutz Luedemann; Simone Spuler
Journal:  Radiology       Date:  2008-11-10       Impact factor: 11.105

View more
  1 in total

1.  Magnetic resonance imaging of the pancreas in streptozotocin-induced diabetic rats: Gadofluorine P and Gd-DOTA.

Authors:  Hye Rim Cho; Youkyung Lee; Philip Doble; David Bishop; Dominic Hare; Young-Jae Kim; Kwang Gi Kim; Hye Seung Jung; Kyong Soo Park; Seung Hong Choi; Woo Kyung Moon
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.